Dealcast: The M&A Podcast

Could tomorrow’s groceries come from a lab? Today’s vertical-farming startups aim to grow food in tightly controlled indoor stacks, solving a host of problems – blight, water wastage and a shortage of land – at once. Leading the way are such firms as the UK’s Intelligent Growth Solutions, Belgium’s Urban Crop Solutions and Italy’s Planet Farms, all of which featured i

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to

German media conglomerate Axel Springer [ETR:SPR] has caught the eye of KKR [NYSE:KKR]. With Axel Springer’s founding family supporting its bid, KKR has an easier route towards taking the target off the market. Activistmonitor editor William Mace and Mergermarket’s resident DACH expert Emma-Victoria Farr joined us to discuss what the deal could mean for Axel Springer’s future

This 15-minute podcast discusses Asian deals and events of interest to hedge funds and other professional investors.

In this weekly edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Anette Jönsson discuss key developments on several Asian situations, including comments by Malaysia’s prime minister indicating Australian rare earth producer Lynas [ASX:LYC] will be allowed to continue operating in the Southeast Asian country; and the potential implications of casino tycoon Jam

Seyfarth’s Paul Pryzant and SRS Acquiom's Chris Letang join Tom Cane to discuss how the shift from a seller’s to a buyer’s M&A market this year has impacted the deal terms being agreed in the mid-market, from an increase in earn-outs and termination fees to the impact of the pandemic on reps and warranties. Paul and Chris also discuss how technology is changing the due di

Wobbly tech-sector IPOs, including those of Uber [NYSE:UBER] and Finablr [LON:FIN], have dampened the mood for ECM. Dealreporter ECM editor Gustav Sandstrom joined us to discuss how these high-profile fumbles could affect similar listings ahead this year.

Mergermarket's ECM Editor, Sofia Cerqueira, joins Julie-Anna to discuss the global SPACs boom and how it's picking up pace in Europe. Julie-Anna is also joined by Co-Heads of SS&C Intralinks, Ken Bisconti and Bob Petrocchi, to discuss the latest Deal Flow Predictor.

No sector is closer than healthcare to the front-lines of the covid-19 pandemic. Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A. In this week’s podcast, Mergermarket healthcare

In this inaugural edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Ed Vinales discuss the appointment of a new head of China’s State Administration for Market Regulation (SAMR), and how the US-China trade dispute is impacting Wesfarmer’s hostile bid for rare-earth miner Lynas. Other situations covered include the hairy privatisation of Hong Kong’s Harbin